Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tuscany project: cannabis preparations for aromatase inhibitor-induced chronic pain in breast cancer patients
2021-002217-34Phase 3Terminated
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Oct 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic pain and breast cancer comparing Cannabis FM2 oil + usual care with Placebo oil + usual care (2 arms). Primary endpoint: Efficacy and safety of Cannabis galenic preparations. Started Oct 2021; status: terminated.
02
Drugs
cannabis FM2 oil
03
Conditions
chronic painbreast cancer
Beyond the preview
Go deeper on 2021-002217-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002217-34.